Nanoformulated fenbendazole as an attractive approach for treating neurocysticercosis: <i>in vitro</i> and <i>in vivo</i> studies
These findings suggest that nanoformulated fenbendazole may be considered a valuable approach for an effective treatment of neurocysticercosis.
Authors
- Guaraciara de Andrade Picanço (ORCID: https://orcid.org/0000-0002-4681-0813)
- Jéssica Yonara de Souza (ORCID: https://orcid.org/0000-0003-4068-8615)
- Claudio J. Salomón (ORCID: https://orcid.org/0000-0003-1599-790X)
- Marina Clare Vinaud (ORCID: https://orcid.org/0000-0002-6746-9191)
- Waylla Silva Nunes
- Giselle Bedogni (ORCID: https://orcid.org/0009-0007-2020-1466)
- Lina Vargas Michelena
- Tatiane Luiza da Costa (ORCID: https://orcid.org/0000-0003-0525-2509)
- Geovana Batista de Campos (ORCID: https://orcid.org/0000-0002-4577-6748)
- Yngrid Batista da Silva
Institutions
- National University of Rosario (AR)
- Centro Científico Tecnólogico - Rosario (AR)
- Institute of Physics Rosario (AR)
- Universidade Federal de Catalão (BR)
- Universidade Federal de Goiás (BR)
Publication Details
- Journal
- Pharmaceutical Development and Technology
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1080/10837450.2024.2422936
- Citations
- 4
- Primary Topic
- Parasitic infections in humans and animals
- Type
- article
- Field-Weighted Citation Impact
- 1.70